Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease

Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confoundin...

Full description

Saved in:
Bibliographic Details
Published inHypertension (Dallas, Tex. 1979) Vol. 73; no. 6; pp. 1202 - 1209
Main Authors Welsh, C.E., Welsh, Paul, Jhund, Pardeep, Delles, Christian, Celis-Morales, C., Lewsey, J.D., Gray, S., Lyall, D., Iliodromiti, S., Gill, J.M.R., Sattar, Naveed, Mark, Patrick B.
Format Journal Article
LanguageEnglish
Published United States American Heart Association, Inc 01.06.2019
Subjects
Online AccessGet full text
ISSN0194-911X
1524-4563
1524-4563
DOI10.1161/HYPERTENSIONAHA.119.12726

Cover

Abstract Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake.
AbstractList Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake.
Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake.Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with hypertension. Low sodium intake has been associated with increased mortality in observational studies. Further studies should assess whether confounding relationships explain associations between sodium intake and outcomes. We studied UK Biobank participants (n=457 484; mean age, 56.3 years; 44.7% men) with urinary electrolytes and blood pressure data. Estimated daily urinary sodium excretion was calculated using Kawasaki formulae. We analyzed associations between sodium excretion and blood pressure in subjects without cardiovascular disease, treated hypertension, or diabetes mellitus at baseline (n=322 624). We tested relationships between sodium excretion, incidence of fatal and nonfatal cardiovascular disease, heart failure, and mortality. Subjects in higher quintiles of sodium excretion were younger, with more men and higher body mass index. There was a linear relationship between increasing urinary sodium excretion and blood pressure. During median follow-up of 6.99 years, there were 11 932 deaths (1125 cardiovascular deaths) with 10 717 nonfatal cardiovascular events. There was no relationship between quintile of sodium excretion and outcomes. These relationships were unchanged after adjustment for comorbidity or excluding subjects with events during the first 2 years follow-up. No differing risk of incident heart failure (1174 events) existed across sodium excretion quintiles. Urinary sodium excretion correlates with elevated blood pressure in subjects at low cardiovascular risk. No pattern of increased cardiovascular disease, heart failure, or mortality risk was demonstrated with either high or low sodium intake.
Author Welsh, Paul
Iliodromiti, S.
Mark, Patrick B.
Lewsey, J.D.
Sattar, Naveed
Welsh, C.E.
Delles, Christian
Gill, J.M.R.
Jhund, Pardeep
Celis-Morales, C.
Gray, S.
Lyall, D.
AuthorAffiliation From the Institute of Cardiovascular and Medical Sciences (C.E.W., P.W., P.J., C.D., C.C.-M., S.G., J.M.R.G., N.S., P.B.M.) Institute of Health and Wellbeing (J.D.L., D.L.), University of Glasgow, United Kingdom Women’s Health Research Division, Queen Mary University of London, United Kingdom (S.I.)
AuthorAffiliation_xml – name: From the Institute of Cardiovascular and Medical Sciences (C.E.W., P.W., P.J., C.D., C.C.-M., S.G., J.M.R.G., N.S., P.B.M.) Institute of Health and Wellbeing (J.D.L., D.L.), University of Glasgow, United Kingdom Women’s Health Research Division, Queen Mary University of London, United Kingdom (S.I.)
Author_xml – sequence: 1
  givenname: C.E.
  surname: Welsh
  fullname: Welsh, C.E.
  organization: From the Institute of Cardiovascular and Medical Sciences (C.E.W., P.W., P.J., C.D., C.C.-M., S.G., J.M.R.G., N.S., P.B.M.) Institute of Health and Wellbeing (J.D.L., D.L.), University of Glasgow, United Kingdom Women’s Health Research Division, Queen Mary University of London, United Kingdom (S.I.)
– sequence: 2
  givenname: Paul
  surname: Welsh
  fullname: Welsh, Paul
– sequence: 3
  givenname: Pardeep
  surname: Jhund
  fullname: Jhund, Pardeep
– sequence: 4
  givenname: Christian
  surname: Delles
  fullname: Delles, Christian
– sequence: 5
  givenname: C.
  surname: Celis-Morales
  fullname: Celis-Morales, C.
– sequence: 6
  givenname: J.D.
  surname: Lewsey
  fullname: Lewsey, J.D.
– sequence: 7
  givenname: S.
  surname: Gray
  fullname: Gray, S.
– sequence: 8
  givenname: D.
  surname: Lyall
  fullname: Lyall, D.
– sequence: 9
  givenname: S.
  surname: Iliodromiti
  fullname: Iliodromiti, S.
– sequence: 10
  givenname: J.M.R.
  surname: Gill
  fullname: Gill, J.M.R.
– sequence: 11
  givenname: Naveed
  surname: Sattar
  fullname: Sattar, Naveed
– sequence: 12
  givenname: Patrick
  surname: Mark
  middlename: B.
  fullname: Mark, Patrick B.
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31067194$$D View this record in MEDLINE/PubMed
BookMark eNqNkV9PFDEUxRuDkQX9Cqa--cBg2-nOTB-MWdfFJUEgLER9mnTb22yhO8X-EfkafmILiz6QmPB0k3N_5zycs4O2Bj8AQm8o2ae0oe_m309nZ-ez48XhyfFkPimi2KesZc0zNKJjxis-buotNCJU8EpQ-m0b7cR4SQjlnLcv0HZNSdOW5wj9vgh2kOEWL7y2eY1nv1SAZP2whz867zU-DRBjDrCH5aDxmY1X2Bt8kFPR8FQGbf1PGVV2MuBPNoKMcE9-8SFJZ9MttgNe5OUlqBTxV5tWPqeSan34j_0lem6ki_Dq4e6ii4PZ-XReHZ18PpxOjirFu66poDUdaTmQbiy0aYhsecMoEW3HqNRNy0g9llKZZWc4NUybThqmNCG6awwIVe-it5vc6-B_ZIipX9uowDk5gM-xZ6ymgtSUkoK-fkDzcg26vw52XUrr__ZYALEBVPAxBjD_EEr6u836R5sVUfT3mxXvh0deZZO82yAFad2TEt5vEm68SxDilcs3EPoVSJdWT_D_AdTntdI
CitedBy_id crossref_primary_10_1161_HYPERTENSIONAHA_119_13349
crossref_primary_10_3389_fcvm_2024_1418059
crossref_primary_10_1016_S0140_6736_19_32008_2
crossref_primary_10_1161_CIRCRESAHA_121_318083
crossref_primary_10_1016_j_ekir_2020_05_025
crossref_primary_10_1161_JAHA_119_014978
crossref_primary_10_1016_j_ihj_2023_12_005
crossref_primary_10_1186_s40885_023_00259_0
crossref_primary_10_1161_JAHA_123_030353
crossref_primary_10_3390_nu12113442
crossref_primary_10_1111_joim_13194
crossref_primary_10_1002_bab_2383
crossref_primary_10_1177_1559827620915708
crossref_primary_10_3390_ijerph17082811
crossref_primary_10_1017_S0007114521001768
crossref_primary_10_3390_nu13093232
crossref_primary_10_4162_nrp_2023_17_2_175
crossref_primary_10_1038_s41598_022_09852_z
crossref_primary_10_3389_fpubh_2022_857818
crossref_primary_10_3390_nu15234898
crossref_primary_10_1161_JAHA_122_026578
crossref_primary_10_1038_s41581_021_00533_0
crossref_primary_10_1161_HYPERTENSIONAHA_120_16668
crossref_primary_10_1097_HJH_0000000000003959
crossref_primary_10_1111_joim_13233
crossref_primary_10_1016_j_jjcc_2021_04_013
crossref_primary_10_1161_HYPERTENSIONAHA_120_16549
crossref_primary_10_1016_j_isci_2023_106728
crossref_primary_10_1002_smll_202403385
crossref_primary_10_1186_s12916_022_02691_9
crossref_primary_10_1016_j_jeem_2024_102954
crossref_primary_10_2147_DMSO_S337032
crossref_primary_10_1371_journal_pone_0265429
crossref_primary_10_1093_eurheartj_ehaa586
crossref_primary_10_3389_fendo_2023_1124479
crossref_primary_10_3389_fnut_2024_1395016
crossref_primary_10_15829_1728_8800_2020_2612
crossref_primary_10_1007_s00394_021_02595_z
crossref_primary_10_1161_HYPERTENSIONAHA_119_13321
crossref_primary_10_1093_advances_nmaa049
crossref_primary_10_1038_s41430_023_01354_z
crossref_primary_10_1097_MD_0000000000040497
crossref_primary_10_1016_j_semnephrol_2023_151407
crossref_primary_10_1038_s41598_020_74657_x
crossref_primary_10_1017_S0007114520004122
crossref_primary_10_3390_nu13093177
crossref_primary_10_1016_j_appr_2021_100091
crossref_primary_10_1001_jamacardio_2024_5410
crossref_primary_10_1093_eurheartj_ehac599
crossref_primary_10_3390_nu12113591
crossref_primary_10_1038_s41591_024_03010_w
crossref_primary_10_1161_HYPERTENSIONAHA_119_13818
crossref_primary_10_1097_HJH_0000000000002647
crossref_primary_10_1161_HYPERTENSIONAHA_119_14028
crossref_primary_10_1161_HYPERTENSIONAHA_119_14302
crossref_primary_10_1093_ehjopen_oead024
crossref_primary_10_1186_s12872_025_04619_6
crossref_primary_10_5334_gh_1187
Cites_doi 10.1136/bmj.f1326
10.1016/0021-9681(87)90171-8
10.1001/jama.2011.574
10.1161/CIRCULATIONAHA.117.029193
10.1056/NEJMoa1311889
10.1161/HYPERTENSIONAHA.111.00566
10.1172/JCI88530
10.1161/CIR.0000000000000485
10.1681/ASN.2016060662
10.1111/j.1440-1681.1993.tb01496.x
10.1016/S0140-6736(09)60144-6
10.1136/bmj.f1325
10.1001/jama.2011.1729
10.2337/dc10-1722
10.1056/NEJMoa1311989
10.1161/01.CIR.49.6.1132
10.1161/01.HYP.25.6.1144
10.1016/j.jamda.2017.09.004
10.1016/S0140-6736(18)31724-0
10.1038/ki.2013.367
10.1002/14651858.CD004022.pub4
10.1371/journal.pmed.1001779
10.1161/01.cir.0000437740.48606.d1
10.1016/S0140-6736(16)31134-5
10.1161/HYPERTENSIONAHA.118.11103
10.1161/01.CIR.77.1.53
10.1001/jama.2016.4447
10.1093/eurheartj/ehx035
10.1056/NEJMra064486
10.2337/dc10-1723
10.1056/NEJM200101043440101
10.1093/oxfordjournals.aje.a116012
10.1097/HJH.0000000000000122
10.1016/S0140-6736(18)31376-X
ContentType Journal Article
Copyright 2019 American Heart Association, Inc
Copyright_xml – notice: 2019 American Heart Association, Inc
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1161/HYPERTENSIONAHA.119.12726
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1524-4563
EndPage 1209
ExternalDocumentID 31067194
10_1161_HYPERTENSIONAHA_119_12726
10.1161/HYPERTENSIONAHA.119.12726
Genre Research Support, Non-U.S. Gov't
Multicenter Study
Journal Article
GeographicLocations United Kingdom
GeographicLocations_xml – name: United Kingdom
GrantInformation_xml – fundername: Medical Research Council
  grantid: MR/N015177/1
– fundername: Medical Research Council
  grantid: MR/N015177/2
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
18M
1J1
2WC
3O-
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
71W
77Y
7O~
AAAAV
AAAXR
AAFWJ
AAGIX
AAHPQ
AAIQE
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAXQO
AAYEP
ABASU
ABBUW
ABDIG
ABJNI
ABOCM
ABPXF
ABQRW
ABVCZ
ABXVJ
ABXYN
ABZAD
ABZZY
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACLDA
ACWDW
ACWRI
ACXJB
ACXNZ
ACZKN
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFBFQ
AFDTB
AFEXH
AFFNX
AFNMH
AFUWQ
AGINI
AHMBA
AHOMT
AHQNM
AHQVU
AHRYX
AHVBC
AIJEX
AINUH
AJCLO
AJIOK
AJNWD
AJNYG
AJZMW
AKCTQ
AKULP
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
AMJPA
AMKUR
AMNEI
AOHHW
AOQMC
BAWUL
BCGUY
BOYCO
BQLVK
BS7
C1A
C45
CS3
DIK
DIWNM
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
GX1
H0~
H13
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K-A
K-F
K8S
KD2
KMI
KQ8
L-C
L7B
N4W
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OB3
OCUKA
ODA
ODMTH
OGROG
OHYEH
OK1
OL1
OLG
OLH
OLU
OLV
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OWBYB
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
PQQKQ
R58
RAH
RIG
RLZ
S4R
S4S
T8P
TEORI
TR2
TSPGW
V2I
VVN
W3M
W8F
WH7
WOQ
WOW
X3V
X3W
X7M
XXN
XYM
YFH
YHZ
YOC
YYM
YYP
ZFV
ZGI
ZZMQN
AAYXX
ADGHP
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
OZ-
7X8
ADKSD
ADSXY
ID FETCH-LOGICAL-c4886-e7f8074e0859df60a74621097821ad672035aacfb8f41f2df8af2cd00d86fe9c3
ISSN 0194-911X
1524-4563
IngestDate Mon Sep 08 05:40:26 EDT 2025
Mon Jul 21 06:02:47 EDT 2025
Thu Apr 24 23:02:53 EDT 2025
Tue Jul 01 01:45:03 EDT 2025
Fri May 16 03:49:32 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords blood pressure
heart failure
sodium
cardiovascular diseases
diet
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4886-e7f8074e0859df60a74621097821ad672035aacfb8f41f2df8af2cd00d86fe9c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.ahajournals.org/doi/pdf/10.1161/HYPERTENSIONAHA.119.12726
PMID 31067194
PQID 2231903110
PQPubID 23479
PageCount 8
ParticipantIDs proquest_miscellaneous_2231903110
pubmed_primary_31067194
crossref_primary_10_1161_HYPERTENSIONAHA_119_12726
crossref_citationtrail_10_1161_HYPERTENSIONAHA_119_12726
wolterskluwer_health_10_1161_HYPERTENSIONAHA_119_12726
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-June
2019-06-00
20190601
PublicationDateYYYYMMDD 2019-06-01
PublicationDate_xml – month: 06
  year: 2019
  text: 2019-June
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Hypertension (Dallas, Tex. 1979)
PublicationTitleAlternate Hypertension
PublicationYear 2019
Publisher American Heart Association, Inc
Publisher_xml – name: American Heart Association, Inc
References e_1_3_4_3_2
e_1_3_4_2_2
e_1_3_4_9_2
e_1_3_4_8_2
e_1_3_4_7_2
e_1_3_4_6_2
e_1_3_4_5_2
e_1_3_4_4_2
e_1_3_4_23_2
e_1_3_4_20_2
e_1_3_4_21_2
e_1_3_4_26_2
e_1_3_4_27_2
e_1_3_4_24_2
e_1_3_4_25_2
e_1_3_4_28_2
e_1_3_4_29_2
e_1_3_4_30_2
Townsend P PM (e_1_3_4_17_2) 1988
Mancilha-Carvalho JJ (e_1_3_4_22_2) 1989; 3
e_1_3_4_11_2
e_1_3_4_34_2
e_1_3_4_12_2
e_1_3_4_33_2
e_1_3_4_32_2
e_1_3_4_10_2
e_1_3_4_31_2
e_1_3_4_15_2
e_1_3_4_16_2
e_1_3_4_37_2
e_1_3_4_13_2
e_1_3_4_36_2
e_1_3_4_14_2
e_1_3_4_35_2
e_1_3_4_19_2
e_1_3_4_18_2
31230541 - Hypertension. 2019 Aug;74(2):e26. doi: 10.1161/HYPERTENSIONAHA.119.13321.
31230548 - Hypertension. 2019 Aug;74(2):e27-e28. doi: 10.1161/HYPERTENSIONAHA.119.13349.
References_xml – ident: e_1_3_4_9_2
  doi: 10.1136/bmj.f1326
– ident: e_1_3_4_19_2
  doi: 10.1016/0021-9681(87)90171-8
– ident: e_1_3_4_13_2
  doi: 10.1001/jama.2011.574
– ident: e_1_3_4_6_2
  doi: 10.1161/CIRCULATIONAHA.117.029193
– ident: e_1_3_4_11_2
  doi: 10.1056/NEJMoa1311889
– ident: e_1_3_4_35_2
  doi: 10.1161/HYPERTENSIONAHA.111.00566
– ident: e_1_3_4_37_2
  doi: 10.1172/JCI88530
– ident: e_1_3_4_2_2
  doi: 10.1161/CIR.0000000000000485
– ident: e_1_3_4_36_2
  doi: 10.1681/ASN.2016060662
– ident: e_1_3_4_18_2
  doi: 10.1111/j.1440-1681.1993.tb01496.x
– ident: e_1_3_4_33_2
  doi: 10.1016/S0140-6736(09)60144-6
– ident: e_1_3_4_8_2
  doi: 10.1136/bmj.f1325
– ident: e_1_3_4_12_2
  doi: 10.1001/jama.2011.1729
– ident: e_1_3_4_26_2
  doi: 10.2337/dc10-1722
– ident: e_1_3_4_4_2
  doi: 10.1056/NEJMoa1311989
– ident: e_1_3_4_23_2
  doi: 10.1161/01.CIR.49.6.1132
– ident: e_1_3_4_24_2
  doi: 10.1161/01.HYP.25.6.1144
– ident: e_1_3_4_27_2
  doi: 10.1016/j.jamda.2017.09.004
– ident: e_1_3_4_14_2
  doi: 10.1016/S0140-6736(18)31724-0
– ident: e_1_3_4_34_2
  doi: 10.1038/ki.2013.367
– ident: e_1_3_4_29_2
  doi: 10.1002/14651858.CD004022.pub4
– ident: e_1_3_4_16_2
  doi: 10.1371/journal.pmed.1001779
– ident: e_1_3_4_10_2
  doi: 10.1161/01.cir.0000437740.48606.d1
– ident: e_1_3_4_3_2
  doi: 10.1016/S0140-6736(16)31134-5
– ident: e_1_3_4_31_2
  doi: 10.1161/HYPERTENSIONAHA.118.11103
– volume-title: Health and Deprivation. Inequality and the North
  year: 1988
  ident: e_1_3_4_17_2
– volume: 3
  start-page: 309
  year: 1989
  ident: e_1_3_4_22_2
  article-title: Blood pressure and electrolyte excretion in the Yanomamo Indians, an isolated population.
  publication-title: J Hum Hypertens
– ident: e_1_3_4_5_2
  doi: 10.1161/01.CIR.77.1.53
– ident: e_1_3_4_25_2
  doi: 10.1001/jama.2016.4447
– ident: e_1_3_4_30_2
  doi: 10.1093/eurheartj/ehx035
– ident: e_1_3_4_20_2
  doi: 10.1056/NEJMra064486
– ident: e_1_3_4_28_2
  doi: 10.2337/dc10-1723
– ident: e_1_3_4_7_2
  doi: 10.1056/NEJM200101043440101
– ident: e_1_3_4_21_2
  doi: 10.1093/oxfordjournals.aje.a116012
– ident: e_1_3_4_32_2
  doi: 10.1097/HJH.0000000000000122
– ident: e_1_3_4_15_2
  doi: 10.1016/S0140-6736(18)31376-X
– reference: 31230548 - Hypertension. 2019 Aug;74(2):e27-e28. doi: 10.1161/HYPERTENSIONAHA.119.13349.
– reference: 31230541 - Hypertension. 2019 Aug;74(2):e26. doi: 10.1161/HYPERTENSIONAHA.119.13321.
SSID ssj0014447
Score 2.5314796
Snippet Hypertension is a risk factor for cardiovascular disease. Increased urinary sodium excretion, representing dietary sodium intake, is associated with...
SourceID proquest
pubmed
crossref
wolterskluwer
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1202
SubjectTerms Biomarkers - urine
Blood Pressure - physiology
Cardiovascular Diseases - mortality
Cardiovascular Diseases - physiopathology
Cardiovascular Diseases - urine
Cause of Death - trends
Female
Humans
Male
Middle Aged
Retrospective Studies
Risk Assessment - methods
Risk Factors
Sodium - urine
Survival Rate - trends
United Kingdom - epidemiology
Title Urinary Sodium Excretion, Blood Pressure, and Risk of Future Cardiovascular Disease and Mortality in Subjects Without Prior Cardiovascular Disease
URI https://www.ncbi.nlm.nih.gov/pubmed/31067194
https://www.proquest.com/docview/2231903110
Volume 73
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1da9swFBVZB6FjjH0v-0KFvbXOYtmR7cdsTQmFlsIa2j0Z2ZJottUObsLKfsb-yf7h7pVk1-ka1u0lBCWSIfdEOlc654qQd5JpLFIUeDnPIEHhgfTiPMq8LErYMFAiygdocD445JNpuH86PO10frVUS8tF1s9_3Ogr-Z-oQhvEFV2y_xDZZlBogPcQX3iFCMPrrWI8rayb9lMpZ8vz7fFljp5Ee47-ARXpzv1n95mNFdEpyfdMKRGUe7TVqLv2tMaKLwwvR44-K3B6-WJkHyezxRkqmY-qWVmt6d7muxNIcysjkjcoi3dx394qk9Rlf9tPoqS1F3ECC7U98rkySDRtbQ3j_tmycAS4kkrNGzqOxxCtogk19t22BjqpavlVX7mpmIUe0LugPVfba08cJtsTr8-McfuGFYHjijD5fDSG_OAQF6jRZATNSd9nkTXrt5AyPzdQCbCwnm9vX75Wjrv-6A65yyKga-gvP21URZCehlGXbLknv1_73E3SrUdaZUR_pDn3yP3vJSonLr4a40SL_hw_JA9c3kJHFoSPSEcVj0n3wCkznpCfDovUYpE2WNyhBom0RuIOBXRRxCEtNbU4pKtAog5I5psNDumsoDUOqcMhNThc0_0pme6Njz9OPHffh5fDMsI9FWkszaSw5p7UfCCikDNUSMTMF5KjYGAoRK6zWIe-ZlLHQrNcDgYy5lolefCMbBRloV4QmmgpJNBT5SsfcvqhCIUKQsmFzpDzxj0S1795mrti-Hgny7fUJMXcT69FDhqT1ESuR1jTdW4rwtym01Yd2BTmbzyUE4Uqlxcp0HPg5AGw8B55biPeDFsjpEf4CgRS65H--2Nfrh3yFdm8-te9JhuLaqneAL1eZG8NoH8D4JbOSQ
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Urinary+Sodium+Excretion%2C+Blood+Pressure%2C+and+Risk+of+Future+Cardiovascular+Disease+and+Mortality+in+Subjects+Without+Prior+Cardiovascular+Disease&rft.jtitle=Hypertension+%28Dallas%2C+Tex.+1979%29&rft.au=Welsh%2C+C+E&rft.au=Welsh%2C+Paul&rft.au=Jhund%2C+Pardeep&rft.au=Delles%2C+Christian&rft.date=2019-06-01&rft.eissn=1524-4563&rft.volume=73&rft.issue=6&rft.spage=1202&rft_id=info:doi/10.1161%2FHYPERTENSIONAHA.119.12726&rft_id=info%3Apmid%2F31067194&rft.externalDocID=31067194
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0194-911X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0194-911X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0194-911X&client=summon